Renalytix Reports Financial Results for First Quarter of : v

Renalytix Reports Financial Results for First Quarter of

NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro...

Related Keywords

New York , United States , Salt Lake City , Utah , University Of Utah , United Kingdom , Canada , Syracuse , London , City Of , America , American , Nicholas Moore , Renalytix Kidneyintel , Paul Mcmanus Lianne Cawthorne , Peter Denardo , James Mccullough , Gary Clarence Daniel Adams , Jed Fulk , Exchange Commission On , Trinity Health , Capital District Physicians Health Plan , Atrium Health , Nasdaq , Capital District Physician Health Plan , United Kingdom International Dial , Veterans Health Administration , Astrazeneca , Trinity Health System , York State Department Of Health , Uva Health System , Veterans Health Administration Is America , Us Canada Participant International Dial , Centers For Medicare Medicaid Services , London Stock Exchange , Uva Health , Wake Forest Baptist Health , Joseph Health , Kantaro Biosciences , Drug Administration , Clinical Laboratory Fee Schedule , Investec Bank , Exchange Commission , American Medical Association , Icahn School Of Medicine At Mount Sinai , Services Administration , Mount Sinai Health System , Wake Forest , Blue Cross Shield , Healthcare Conference , Mount Sinai , Call Details , Canada Participant Toll Free Dial In Number , Canada Participant International Dial In Number , Kingdom International Dial In Number , Kingdom Local Dial In Number , Nominated Adviser , Joint Broker , Breakthrough Designation , Private Securities Litigation Reform Act , Financial Results , Three Months Ended September , Annual Report , London Stock , Nasdaq Global Market , Medicaid Services , York State Department , Common Procedural Terminology , American Medical , Renalytix Kidneyintelx , New York State , General Services Administration , Laboratory Fee Schedule , Emergency Use Authorization , Contract Liability , Icahn School , Currency Gain , Value Adjustments , Cash Equivalents , Nasdaq Rnlx , Renalytix Plc ,

© 2025 Vimarsana